Will Omicron trigger another Economic Slowdown?
GT Molecular announces a highly sensitive wastewater testing service for the Omicron Coronavirus variant
GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels, has announced the upcoming release of its sensitive PCR tests to monitor the coronavirus Omicron variant, B.1.1.529. (Source- prnewswire)
Biocartis’ Idylla™ SARS-CoV-2 testing successfully detects Omicron variant
Biocartis Group NV announced that the company performed an in-silico analysis which concluded that the Idylla™ SARS-CoV-2 Test (CE-IVD) and the Idylla™ SARS-CoV-2/Flu/RSV1 Panel (CE-IVD) detect the currently available B.1.1.529/Omicron sequences, the new variant of concern causing COVID-19 disease. (Source- globenewswire)
Tevogen Bio has been granted a patent for the method of preparing COVID-19 peptide specific T cells, and methods of treating COVID-19 using CTL therapy
Tevogen Bio announced the issuance of a patent which significantly reinforces Tevogen’s intellectual property position in use of SARS-CoV-2 specific Cytotoxic CD8+ T Lymphocytes (CTL) immunotherapy for treatment of COVID-19. Dr. Neal Flomenberg, MD, said, our therapeutic targets are not affected in the Delta variant and appear preserved in the Omicron variant as well. (Source- businesswire)
POSTECH team develops testing method to detect Omicron variant
A research team at Pohang University of Science and Technology (POSTECH) has developed a diagnostic technology to detect the Covid-19 variant Omicron in just 20 minutes. The researchers are preparing to apply for a patent for commercialization. (Source- koreabiomed)
Gb Sciences targets COVID-19 treatment as Omicron variant arrives
Gb Sciences has reported positive results from a study of its potential treatment for cytokine release syndrome (CRS), one of the most dangerous complications of COVID-19. With the arrival of Omicron variant, Gb Sciences plans to move quickly through the development stages for this novel CRS therapy. (Source- globenewswire)
Copper fresh masks to restrict the spread of Covid-19
The Copper fresh mask’s introduction, comes at an apt time, considering the detection of the Omicron variant just over two weeks ago. The masks offer dual-side protection with 99.9% bacterial filtration. The mask kills the virus just a few minutes after it touches the mask. (Source – iol.co)
GreenLight (ENVI) and IAVI begin work on Omicron variant-adapted COVID-19 vaccine candidate
GreenLight Biosciences (ENVI) and IAVI, a nonprofit scientific research organization announced work on a messenger RNA vaccine candidate to tackle the COVID-19 Omicron variant. GreenLight’s Covid-19 vaccine candidate will begin clinical trials in South Africa next year. (Source- prnewswire)
Seegene’s new PCR test identifies the Omicron variant, its stealth version and all VOCs in a single tube
Seegene Inc. unveiled series of diagnostic test that detects the ever-changing COVID-19 variant landscape. The Novaplex™ SARS-CoV-2 variants VII assay addresses Omicron and its stealth version, as well as other variants. (Source- prnewswire)
0 Comments